Cardiometabolic Disease Market Trends Driven by Advances in Disease Management 2034
Clinical research remains an important factor influencing the Cardiometabolic Disease Market. Pharmaceutical and biotechnology companies are investigating therapies that address multiple biological pathways associated with metabolic and cardiovascular disease. The cardiometabolic disease market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in 2025, registering a CAGR...
0 Comments 0 Shares 10 Views 0 Reviews